or required for compliance

Core Annex 11 Expectations (What Auditors Actually Check)

1) Risk Management Approach

Annex 11 pushes a risk-based approach: you apply controls and validation effort proportional to patient risk and data criticality. This typically means critical systems (batch release, sterility data, critical alarms) get stronger controls than low-risk support tools.

2) Validation Throughout the Lifecycle

Systems must be validated for intended use, and validation must remain valid after updates and changes. You must show documented requirements, testing evidence, and controlled change management.

3) Supplier and Service Provider Assessment

Annex 11 expects you to assess suppliers and service providers (including SaaS vendors) based on risk. You don’t outsource responsibility—supplier oversight is part of GMP control.

4) Data Integrity Controls and Audit Trails

Annex 11 expects appropriate controls to protect data from loss or unauthorized change, including audit trails where relevant. Audit trails must be available, enabled where needed, and reviewed based on risk for key records.

5) Security and Access Management

• Unique user IDs and role-based access
• Proper segregation of duties (e.g., create vs approve)
• User provisioning and periodic access reviews
• Controls for administrators (admin activities should be limited and logged)

6) Data Storage, Backup, and Restore

Systems must protect records from loss. It’s not enough to say “we back up.” You must be able to demonstrate you can restore data reliably and that backups include raw data and metadata needed to reconstruct GMP evidence.

7) Change Control and Configuration Management

Software patches, configuration changes, interface changes, and master data changes must be controlled. Annex 11 auditors often focus on whether “small changes” bypassed validation and created silent risk.

8) Business Continuity and Incident Management

Annex 11 expects you to manage incidents (system failures, security events, data corruption) and have defined business continuity procedures so GMP operations do not collapse when systems fail.

Annex 11 vs 21 CFR Part 11 (Straight Comparison)

These are not identical, but they overlap heavily. A practical way to view it:

• 21 CFR Part 11 (FDA): focuses on controls for electronic records and electronic signatures (trustworthiness and equivalence to paper).
• EU GMP Annex 11: broader lifecycle expectations for computerised systems in GMP (risk management, supplier oversight, security, validation, data integrity).

Many companies design one integrated CSV/data integrity program that satisfies both, because core controls (validation, audit trails, access, change control) are common.

Mini Example: Annex 11 Risk-Based Audit Trail Review

Scenario: Your LIMS stores release testing results. A solid Annex 11 approach might define:

• Which audit trail events are critical (result changes, approval changes, login failures, role changes)
• Who reviews the audit trail (QA or independent reviewer, not only the analyst)
• How often it is reviewed (per batch, weekly, or risk-defined frequency)
• What evidence is retained (audit trail reports attached to batch record review pack)

This turns audit trail review from “we can export it” into “we actively use it as a compliance control.”

Common Annex 11 Compliance Gaps (Audit Traps)

• No documented risk assessment: validation effort not justified
• Weak supplier oversight: “vendor said it’s validated” without evidence
• Audit trails not reviewed: enabled but ignored
• Shared accounts or uncontrolled admin access: destroys attributable and security expectations
• Interfaces not validated: data transfers between systems can be silent failure points
• Backup without restore testing: no proof records can be recovered
• Change control gaps: patches/config changes implemented without validation assessment

Audit-Ready Talking Points

• Show system inventory and Annex 11 applicability assessment
• Provide risk assessment linking system functions to GMP criticality
• Show validation evidence (requirements, tests, summary reports, traceability)
• Demonstrate access governance (user provisioning, periodic review, admin controls)
• Explain audit trail review procedure and provide real evidence samples
• Show backup/restore testing evidence and business continuity planning

Quick Annex 11 Checklist (Practical)

• Risk assessment documented and controls proportionate
• System validated for intended use and maintained in validated state
• Supplier assessed and responsibilities defined
• Access controls and segregation of duties implemented
• Audit trails enabled and reviewed where required
• Backups performed and restore testing evidenced
• Changes controlled and evaluated for validation impact
• Incidents managed with documented procedures and evidence

FAQs

What is EU GMP Annex 11?

Annex 11 is an EU GMP guideline that defines expectations for computerised systems used in GMP, focusing on validation, risk management, security, data integrity, and lifecycle control.

Is Annex 11 the same as 21 CFR Part 11?

No. Part 11 is a US regulation focused on electronic records and signatures; Annex 11 is an EU guideline with broader computerised system lifecycle expectations. They overlap in many controls.

Does Annex 11 require validation?

Yes. Systems must be validated for intended use, and changes must be controlled to maintain the validated state.

Do we have to review audit trails under Annex 11?

For critical systems and critical data changes, audit trail review is a strong expectation. The frequency and depth should be risk-based and documented.

What is the most common Annex 11 audit finding?

Weak data integrity controls—especially shared accounts, uncontrolled admin access, and audit trails that exist but are not reviewed.